Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Apr 30, 2013 |
not rated yet |
© Medical Xpress 2011-2012 powered by PHYSorg.com